A Phase II Study of CMF in Combination with Anti c-erbB2 Antibody (HerpoeptinR) in Woman with c-erbB2 Positive Metastatic Breast Cancer

Project Details

StatusFinished
Effective start/end date1/07/0930/06/12

Funding

  • Other: £21,981.00